Further large-scale randomized controlled trials, some of which are ongoing, with diverse study populations are necessary to better understand their efficacy, safety, and long-term impact in the treatment of these chronic inflammatory skin conditions
Pregnancy and breastfeeding: Use of retatrutide during pregnancy or breastfeeding is not recommended
Sarcopenia: an undiagnosed condition in older adults
They just feel very proud for (finally) being able to "barely eat." They revel in the number of pounds they have lost, their lower BMIs, and their stylish new clothes
Laboratory studies in photoaging models show that combined peptide approaches addressing multiple regenerative pathways produce superior outcomes compared to single-agent interventions, with improvements in collagen organization, elastin fiber quality, hyaluronic acid content, and overall dermal architecture
Groundbreaking clinical trials published in late 2023 and 2024 show that semaglutide, approved in 2019 for treating diabetes and in 2021 for weight management, also reduces rates of heart disease and kidney disease, and reduces tissue and systemic inflammation